Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP1 | P11387 | 18/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | GLA | P06280 | 3/20 | 1.00 |
| ▸ | MEN1 | O00255 | 3/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 1.00 |
| ▸ | RECQL | P46063 | 2/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.82 |
| ▸ | RAB9A | P51151 | 2/20 | 0.82 |
| ▸ | BLM | P54132 | 2/20 | 0.82 |
| ▸ | MAPT | P10636 | 2/20 | 0.82 |
| ▸ | POLB | P06746 | 1/20 | 0.82 |
| ▸ | ABCC4 | O15439 | 2/20 | 0.78 |
| ▸ | HTT | P42858 | 2/20 | 0.78 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.78 |
| ▸ | ACHE | P22303 | 1/20 | 0.78 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.78 |
| ▸ | ABCC2 | Q92887 | 1/20 | 0.78 |
| ▸ | TP53 | P04637 | 2/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23270615 | 1.00 | TOP1 (1.00) | TOP1ALDH1A1GLAMEN1KMT2A | |
| SCHEMBL1301708 | 1.00 | TOP1 (1.00) | TOP1ALDH1A1GLAMEN1KMT2A | |
| Camptothecin SCHEMBL29056181 | 0.96 | TOP1 (0.92) | TOP1ALDH1A1GLAMEN1KMT2A | |
| SCHEMBL27561956 | 0.92 | TOP1 (1.00) | TOP1ALDH1A1GLAMEN1KMT2A | |
| SCHEMBL1006662 | 0.92 | TOP1 (1.00) | TOP1ALDH1A1GLAMEN1KMT2A | |
| SCHEMBL27489142 | 0.91 | TOP1 (0.85) | TOP1ALDH1A1GLAMEN1KMT2A | |
| SCHEMBL3847426 | 0.91 | TOP1 (0.85) | TOP1ALDH1A1GLAMEN1KMT2A | |
| SCHEMBL1062768 | 0.91 | TOP1 (1.00) | TOP1ALDH1A1GLAMEN1KMT2A | |
| SCHEMBL27502037 | 0.91 | TOP1 (1.00) | TOP1ALDH1A1GLAMEN1KMT2A | |
| SCHEMBL6848647 | 0.90 | TOP1 (0.84) | TOP1ALDH1A1GLAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250177553-A1 | NOVEL ANTIBODY DRUG CONJUGATE | AbTis Co., Ltd. (KR) | 2025-06-05 | — | — | US | disclosed |
| EP-4483907-A1 | NOVEL ANTIBODY DRUG CONJUGATE | ABTIS Co., Ltd. (KR) | 2025-01-01 | — | — | EP | disclosed |
| US-20240084272-A1 | CYTOCHROME P450 MONOOXYGENASES AND USES THEREOF | UNIV BRITISH COLUMBIA (CA) | 2024-03-14 | — | — | US | disclosed |
| CN-116688156-A | Novel hydroxycamptothecin nanoparticle and preparation method and application thereof | 佛山市妇幼保健院 | 2023-09-05 | — | — | CN | disclosed |
| WO-2023163536-A1 | NOVEL ANTIBODY DRUG CONJUGATE | 앱티스 주식회사 | 2023-08-31 | — | — | WO | disclosed |
| WO-2022120490-A1 | CYTOCHROME P450 MONOOXYGENASES AND USES THEREOF | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2022-06-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250177553-A1 | NOVEL ANTIBODY DRUG CONJUGATE | FCGRT, FCGR1A, FCGR3B | TOP1 2001/4885ALDH1A1 1257/4885GLA 2311/4885 |
| US-20240084272-A1 | CYTOCHROME P450 MONOOXYGENASES AND USES THEREOF | CYP3A43, CYP11B2, CYP11B1 | TOP1 367/4885ALDH1A1 208/4885GLA 4035/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.